Table 3 Review of the literature of not-MALAT1 TFEB rearranged renal cell carcinomas.

From: TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1

Case

References

Gene Fusion

Age

Gender

Size

Cathepsin K

HMB45

Melan -A

Follow-up

1

Durinck et al. [13]

CTLC

68

F

n.a.

n.a.

n.a.

n.a.

n.a.

2

Gupta et al. [26]

TGCA-A3-3313-01

Malouf et al. [11]

KHDRBS2

59

M

4.5 cm

n.a.

n.a.

n.a.

no metastasis

3

Gupta et al. [26]

TGCA-B9-A69E-01

CADM2

71

M

8 cm

n.a.

n.a.

n.a.

no metastasis

4

Gupta et al. [26]

TGCA-BQ-7048

COL21A1

64

M

11 cm

n.a.

n.a.

n.a.

metastasis

5

Xia et al. [12]

ACTB

26

M

2 cm

n.a.

n.a.

n.a.

NED 66 months

6

Xia et al. [12]

CTLC

42

M

7 cm

n.a.

n.a.

n.a.

NED 62 months

7

Xia et al. [12]

ACTB

20

F

4 cm

n.a.

n.a.

n.a.

NED 68 months

8

Xia et al. [12]

EWSR1

28

M

6 cm

n.a.

n.a.

n.a.

NED 10 months

9

Xia et al. [12]

PPP1R10a

20

M

5 cm

n.a.

n.a.

n.a.

NED 46 months

10

Present case

NEAT1

55

M

3 cm

100% +

<5% +

80% +

NED 78 months

11

Present case

ACTB

81

F

6.5 cm

5% +

20% +

10% +

NED 12 months

  1. n.a. not available, NED not evidence of disease.
  2. aPotential TFEB fusion partner.